Clinical Trials on Panic in Austria
Total 14 results
-
University of Texas at AustinCompletedPanic Attack | Nicotine AddictionUnited States
-
Baker Heart Research InstituteNational Health and Medical Research Council, AustraliaUnknown
-
Cerevel Therapeutics, LLCRecruitingPanic DisorderUnited States
-
AstraZenecaCompletedMania | Manic Disorder | Manic State | Affective Psychosis, Bipolar | Manic-Depressive Psychosis | Psychoses, Manic-DepressiveUnited States
-
University of Texas at AustinUnknownAnxiety Disorders | Post Traumatic Stress Disorder | Panic Disorder | Social Phobia | PhobiaUnited States
-
The AlfredStanley Medical Research InstituteCompletedSchizophrenia | Schizoaffective Disorder | Schizophreniform Disorder(Not in Manic Phase)Australia
-
University of Texas at AustinBoston University; National Institute of Mental Health (NIMH)RecruitingObsessive-Compulsive Disorder | Generalized Anxiety Disorder | Post Traumatic Stress Disorder | Social Anxiety Disorder | Panic DisorderUnited States
-
Melbourne HealthCompletedSchizoaffective Disorder | Bipolar DisorderAustralia
-
Otsuka Pharmaceutical Development & Commercialization...H. Lundbeck A/SCompletedBipolar I Disorder | Manic EpisodeSerbia, United States, Bulgaria, Poland
-
University of Texas at AustinFreespira, Inc.RecruitingAnxiety Disorders | Generalized Anxiety Disorder | Trauma | Posttraumatic Stress Disorder | Social Anxiety Disorder | Panic Disorder | Agoraphobia | Illness Anxiety Disorder | Acute Stress Disorder | Adjustment Disorder With Anxious MoodUnited States
-
Memory PharmaceuticalsStanley Medical Research InstituteCompletedSafety and Efficacy of MEM 1003 Versus Placebo for the Treatment of Patients With Bipolar I DisorderBipolar Disorder With Manic or Mixed EpisodesUnited States
-
Novartis PharmaceuticalsCompletedBipolar DisorderUnited States, France, Russian Federation
-
Novartis PharmaceuticalsCompletedBipolar DisorderUnited States, Austria, Canada, Colombia, Czech Republic, Germany, Guatemala, Peru, Russian Federation, Slovakia, South Africa, Ukraine, Venezuela
-
NovartisCompletedOpen Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I DisorderBipolar DisorderAustria, Canada, Czech Republic, Germany, Peru, Russian Federation, Slovakia, South Africa, Ukraine, Venezuela, United States, Colombia, Guatemala